Mengshi Li

Mengshi Li

Company: Viewpoint Molecular Targeting, Inc.

Job title: Principal Scientist

Seminars:

Panel Discussion: Striking a Balance: Achieving Anticancer Activity without Toxicity 2:30 pm

Consider how we can investigate toxicity through dosimetry and how this data can be used in regulator submissions Discuss how dosimetry will play a role in taking on new cancer types How can we overcome the lack of clarity around the application and value of dosimetry?Read more

day: Day Two

The Radiochemistry, Preclinical Efficacy & Immunogenicity Of 212Pb- Based Radiopharmaceuticals 2:00 pm

Develop radiochemistry for rapid reaction with Pb-212 and stable chelation of progeny Bi-212 daughters Pb-203 surrogate predicts in vivo biodistribution of Pb-212 and progeny Bi-212 The immunogenicity of alpha-radiotherapy and synergy with immunotherapy in melanomaRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.